These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12021117)

  • 21. Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset.
    Urakami T; Miyamoto Y; Matsunaga H; Owada M; Kitagawa T
    Diabetes Care; 1995 Aug; 18(8):1095-9. PubMed ID: 7587843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenetic, clinical, and demographic characterization of childhood type I diabetes in New Zealand.
    Forbes LV; Scott RS; Brown LJ; Darlow BA
    Diabetes Care; 1995 Nov; 18(11):1428-33. PubMed ID: 8722065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
    Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
    Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
    J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
    Majkowska L
    Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
    Bingley PJ; Williams AJ; Gale EA
    Diabetes Care; 1999 Nov; 22(11):1796-801. PubMed ID: 10546010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
    Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
    Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenetic determinants and prediction of IDDM in French schoolchildren.
    Lévy-Marchal C; Dubois F; Noël M; Tichet J; Czernichow P
    Diabetes; 1995 Sep; 44(9):1029-32. PubMed ID: 7657024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQ beta chain.
    Boehm BO; Seissler J; Glück M; Manfras BJ; Thomas H; Schmidt K; Rudert WA; Usadel KH; Trucco M; Scherbaum WA
    Dis Markers; 1991; 9(5):273-80. PubMed ID: 1797450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Islet cell antibodies].
    Hanafusa T
    Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of islet cell antibodies and B cell functional status in insulin dependent diabetes.
    Merchant PC; Godse CS; Varthakavi PK; Patel KL; Nihalani KD
    J Assoc Physicians India; 1996 Jul; 44(7):457-60. PubMed ID: 9282605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
    Majkowska L; Czekalski S; Skwira J
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
    Borg H; Gottsäter A; Fernlund P; Sundkvist G
    Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
    Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
    Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes.
    Seidel DK; Geiss HC; Donner MG; Ritter MM; Schwandt P; Koll RA; Standl E; Ziegler AG
    J Autoimmun; 1998 Jun; 11(3):273-7. PubMed ID: 9693976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.